Androgens are not only essential for bone development but for the maintenance of bone
mass. Therefore, conditions with androgen deficiency, such as male hypogonadism …

BACKGROUND Polycystic ovary syndrome (PCOS) has reproductive and metabolic aspects
that may affect bone health. Controversial results from different studies regarding the risk of …

Polycystic Ovary Syndrome (PCOS) is a highly prevalent and heterogenous endocrinopathy
affecting 5-18% of women. Although its cardinal features include androgen excess …

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among
premenopausal women. PCOS may have reproductive, metabolic, cardiovascular, and …

PCOS frequently will present during adolescence. These young women may already have
symptoms of metabolic comorbidities. Providers caring for these patients must be aware of …

Context Osteosarcopenia (loss of skeletal muscle and bone mass and/or function usually
associated with aging) shares pathophysiological mechanisms with polycystic ovary …

Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder to affect
women in their reproductive years. There has been growing concern that women with PCOS …

Aim: The aim of this study was to examine the association between endogenous hormones
and bone mineral density (BMD) in postmenopausal women. Materials and Methods: This …

Polycystic ovary syndrome (PCOS) is a complex disorder; various features of this disorder
may influence bone metabolism and skeletal mass. The contribution of PCOS to lower bone …

Context Controversial results have emerged regarding whether PCOS is protective or
increases the risk of bone frailty. Objective This study investigated whether the PCOS …